These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 30037087)

  • 1. PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity.
    Corrales P; Vidal-Puig A; Medina-Gómez G
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors.
    Goto T
    Biosci Biotechnol Biochem; 2019 Apr; 83(4):579-588. PubMed ID: 30572788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARs-Orchestrated Metabolic Homeostasis in the Adipose Tissue.
    Sun C; Mao S; Chen S; Zhang W; Liu C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress on active ingredients of traditional Chinese medicines improved insulin resistance based on PPARs targets].
    Jiang HJ; Zhang XJ; Zhang H; Yan JZ
    Zhongguo Zhong Yao Za Zhi; 2015 Nov; 40(22):4355-8. PubMed ID: 27097406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARs: diverse regulators in energy metabolism and metabolic diseases.
    Wang YX
    Cell Res; 2010 Feb; 20(2):124-37. PubMed ID: 20101262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives.
    Laganà AS; Vitale SG; Nigro A; Sofo V; Salmeri FM; Rossetti P; Rapisarda AM; La Vignera S; Condorelli RA; Rizzo G; Buscema M
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas.
    Souza-Tavares H; Miranda CS; Vasques-Monteiro IML; Sandoval C; Santana-Oliveira DA; Silva-Veiga FM; Fernandes-da-Silva A; Souza-Mello V
    World J Gastroenterol; 2023 Jul; 29(26):4136-4155. PubMed ID: 37475842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARs at the crossroads of lipid signaling and inflammation.
    Wahli W; Michalik L
    Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARs: therapeutic targets for metabolic disease.
    Berger JP; Akiyama TE; Meinke PT
    Trends Pharmacol Sci; 2005 May; 26(5):244-51. PubMed ID: 15860371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
    Yessoufou A; Wahli W
    Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear receptors and nonalcoholic fatty liver disease.
    Cave MC; Clair HB; Hardesty JE; Falkner KC; Feng W; Clark BJ; Sidey J; Shi H; Aqel BA; McClain CJ; Prough RA
    Biochim Biophys Acta; 2016 Sep; 1859(9):1083-1099. PubMed ID: 26962021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.
    Lamichane S; Dahal Lamichane B; Kwon SM
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G; Torres N; Tovar AR
    Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship of lipid imbalance and chronic inflammation mediated by PPAR].
    Čavojský T; Bilka F; Pauliková I
    Ceska Slov Farm; 2016; 65(1):3-9. PubMed ID: 27118498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters.
    Li GS; Liu XH; Zhu H; Huang L; Liu YL; Ma CM; Qin C
    Biol Pharm Bull; 2011; 34(5):644-54. PubMed ID: 21532151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors as attractive antiobesity targets.
    Zhang F; Lavan B; Gregoire FM
    Drug News Perspect; 2004 Dec; 17(10):661-9. PubMed ID: 15696231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARs and the orchestration of metabolic fuel selection.
    Sugden MC; Zariwala MG; Holness MJ
    Pharmacol Res; 2009 Sep; 60(3):141-50. PubMed ID: 19646653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blueberry intake alters skeletal muscle and adipose tissue peroxisome proliferator-activated receptor activity and reduces insulin resistance in obese rats.
    Seymour EM; Tanone II; Urcuyo-Llanes DE; Lewis SK; Kirakosyan A; Kondoleon MG; Kaufman PB; Bolling SF
    J Med Food; 2011 Dec; 14(12):1511-8. PubMed ID: 21861718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PPARs: structure, mechanisms of action and control. Note I].
    Filip-Ciubotaru F; Foia L; Manciuc C; Grigore C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):477-84. PubMed ID: 21870744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.